N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients. - Wikidata - awgldk - TriplyDB

N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.

N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.

http://www.wikidata.org/entity/Q35874750

about

Developments in the identification of glycan biomarkers for the detection of cancer Serum glycoprotein-derived N- and O-linked glycans as cancer biomarkers Simultaneous analyses of N-linked and O-linked glycans of ovarian cancer cells using solid-phase chemoenzymatic method Discovery of specific metastasis-related N-glycan alterations in epithelial ovarian cancer based on quantitative glycomics Purification of derivatized oligosaccharides by solid phase extraction for glycomic analysis Improving N-glycan coverage using HPLC-MS with electrospray ionization at subambient pressure.Lectin array and glycogene expression analyses of ovarian cancer cell line A2780 and its cisplatin-resistant derivate cell line A2780-cp.Serum N-glycome characterization and anti-carbohydrate antibody profiling in oral squamous cell carcinoma patients.The serum glycome to discriminate between early-stage epithelial ovarian cancer and benign ovarian diseases.Polysialylated N-glycans identified in human serum through combined developments in sample preparation, separations, and electrospray ionization-mass spectrometry.Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status Increased sialylation of anti-Thomsen-Friedenreich antigen (CD176) antibodies in patients with gastric cancer: a diagnostic and prognostic potential Sub 2-μm macroporous silica particles derivatized for enhanced lectin affinity enrichment of glycoproteins Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2011-2012.Evaluation of glycomic profiling as a diagnostic biomarker for epithelial ovarian cancer.Comparative profiling of N-glycans isolated from serum samples of ovarian cancer patients and analyzed by microchip electrophoresis.N-linked glycan profiling of GGTA1/CMAH knockout pigs identifies new potential carbohydrate xenoantigens.Isolation and purification of glycoconjugates from complex biological sources by recycling high-performance liquid chromatography The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer Sialic acid methylation refines capillary electrophoresis laser-induced fluorescence analyses of immunoglobulin G N-glycans of ovarian cancer patients.Sample preparation for mass spectrometric analysis of human serum N-glycans using hydrophilic interaction chromatography-based solid phase extraction.Applications of Multiple Reaction Monitoring to Clinical Glycomics.Proteomics in cancer biomarkers discovery: challenges and applications.Examination of glycan profiles from IgG-depleted human immunoglobulins facilitated by microscale affinity chromatography.Quantitation of permethylated N-glycans through multiple-reaction monitoring (MRM) LC-MS/MS N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteins Structural Characterization of Serum N-Glycans by Methylamidation, Fluorescent Labeling, and Analysis by Microchip Electrophoresis.Evaluation of riproximin binding properties reveals a novel mechanism for cellular targeting Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer.Characterization of IgG glycosylation in rheumatoid arthritis patients by MALDI-TOF-MSn and capillary electrophoresis.Smoking and lung cancer-induced changes in N-glycosylation of blood serum proteins.Analytical glycobiology at high sensitivity: current approaches and directions Quantitative glycomics strategies Defining putative glycan cancer biomarkers by MS.B4GALT family mediates the multidrug resistance of human leukemia cells by regulating the hedgehog pathway and the expression of p-glycoprotein and multidrug resistance-associated protein 1 Glycosylation of plasma IgG in colorectal cancer prognosis.Recent trends in analytical and structural glycobiology Enrichment strategies in glycomics-based lung cancer biomarker development.Changes in fucosylation of human seminal IgG and secretory component of IgA in leukocytospermic patients.

P2860

Q27026715-B9916933-8AD1-4937-B840-82E2D57EC465 Q28079101-3E79119B-96E0-45E8-A41E-04F3CD727133 Q28468580-7CDAF726-BA65-48CF-9ECD-31294CB2DBDB Q28539618-7CB35E49-6F8B-4557-AA20-1B80CAC1FDFF Q28542008-DD6A4E88-FA70-4FC2-A694-5C10FA8DAB7B Q33456015-9D1E3063-1E9A-4A8E-80DE-E7A7B5BF6FBC Q33722717-FF5CB83C-1F12-4006-9556-09B1A7F00AA2 Q33778489-DF9409C9-2453-42D7-9B84-33C10B19ECF6 Q34092935-CFF0AE56-3BF4-42E3-BB2A-9580696A54CF Q34120306-2BFE7EF0-9A5B-4B8A-B938-AFABA6D8E411 Q34157637-D040EEB7-0031-4204-8F66-423FE5FC7277 Q34208137-5A9BC42D-0C74-4574-964D-0D0A4BF4CC37 Q34320236-44D87DE0-F180-4231-8953-97E25FFE1BC4 Q34489424-D2D7E993-B9A5-44F2-9395-94319CBA92CE Q34503577-AECB3421-395C-4D47-B188-A9D220E329B4 Q34975642-5B2AE680-B403-4576-B74D-B6C67EE465C5 Q34986720-21E9797B-3581-4689-B1DA-02E37EF673DC Q35000177-E0729D8B-1057-47F6-882C-F424AA9E7002 Q35065968-E244AEA7-EB23-4EF5-8C03-0E281DD3637E Q35165824-3B8E9855-9617-448D-A61F-60A45EBDFDA6 Q35213998-647EC5DC-ACBD-40FD-ADE8-E20188561BB8 Q35447868-D4A819F9-2846-4CEE-9C86-CF0EFE2C265A Q35592114-AFE70D7B-2B12-4278-BD91-529CD4584700 Q35874074-E7C69A13-EAE0-4B63-BC0B-D73D7B609354 Q35886419-1176DF48-1421-441C-9A05-1DC478E76487 Q36076879-56F2E65D-CB1B-480E-B6A2-BE1AE1CC0D2E Q36089872-8417D5FD-4187-4C99-8D0C-117386153E47 Q36098576-60E0889D-6240-4239-B54D-B9438C11D7CA Q36332756-840D5AC9-A10D-4BF2-BEE1-C6ED890C0A47 Q36339643-C2C9B4B3-1673-40DC-B134-D37EF8F01C18 Q36342795-CB10204F-7C1C-40ED-A5A4-6F7207391BEA Q36362594-80654B75-7540-4A94-84D4-890EAD3D88A5 Q36651493-8CDE5DCC-C8E6-4651-B56B-F08AA1BFCB89 Q36742414-D3C17C7A-5A10-4C61-AF4B-04F2F4B84471 Q36904030-64ADE535-93D9-46CA-A0F5-DBDF4E3C573D Q36973762-DF92CEE3-F70E-4E16-961B-3194F8FF7CAA Q37005714-3E9F0950-7AE1-4019-8679-40667D8FE33A Q37297209-1DAD2CF9-3BED-4F81-9223-84D9863A0701 Q37446239-F33D1153-B218-4F11-9691-066C460F7480 Q37480161-1E8884A2-409A-4197-902D-D88A943D0ED6

P2860

N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.

http://www.wikidata.org/entity/Q35874750

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

N-linked glycan structures and ...... ra of ovarian cancer patients.

@ast

N-linked glycan structures and ...... ra of ovarian cancer patients.

@en

type

label

N-linked glycan structures and ...... ra of ovarian cancer patients.

@ast

N-linked glycan structures and ...... ra of ovarian cancer patients.

@en

prefLabel

N-linked glycan structures and ...... ra of ovarian cancer patients.

@ast

N-linked glycan structures and ...... ra of ovarian cancer patients.

@en

P1433

Q35874750-E1252135-DF9A-4C97-80A6-49BC2FCEF297

P1476

Q35874750-9E74FAC7-1345-4987-A8D9-0B05A41440C7

P2093

Q35874750-143993D0-89BA-43D6-BC50-3C1427617451

Q35874750-4D53243D-0046-4310-8560-8BCED0A814AB

Q35874750-5B8AF3E3-EF26-4FD0-BD61-E43194D3498F

Q35874750-5DD4F3D0-B265-4724-9AC2-CCDA83AED793

Q35874750-747679AB-0732-4D28-9724-9E17534E1199

Q35874750-7DA37220-B490-4DFA-BBFC-50BD13111479

Q35874750-C8993DB4-DBCF-4F48-BE9D-D138DDDC4847

P2860

Q35874750-011038E1-31A3-4EE2-84AE-3D5D9A943564

Q35874750-08E4FB66-1D51-4E6E-92B8-0CE0EB5D8332

Q35874750-09444D6D-2878-40FE-AF41-E81BC4B330E3

Q35874750-0AB94221-9E97-4B2A-AE74-3F33F8960117

Q35874750-10BE7F3E-AE3A-4D8B-A044-BF798D2BFD6F

Q35874750-1529B613-9F19-4026-AE57-63BFD35E7732

Q35874750-176209A2-80C9-442E-8228-CF4372FA7CB5

Q35874750-2201EF06-DC05-41B6-8BDB-4C6FBACF6E1F

Q35874750-2554E275-FEC6-4326-806F-3D61A455FF28

Q35874750-2B1E3982-39AA-4D8F-A0DF-83CD25D95998

P304

Q35874750-F3D26036-EA89-4E80-8EEB-3551889F2685

P31

Q35874750-C30073AC-2157-4F13-9222-CC0555AC883C

P356

Q35874750-B99D2AD6-D549-4B55-8661-F212E05E9038

P433

Q35874750-DACC921F-855A-4FAB-909B-AF2B8D1C050C

P478

Q35874750-377835B7-B2EB-42FE-8FB8-CACD500D79CC

P50

Q35874750-06BB24A7-0055-4DD9-B130-3408C617301C

Q35874750-571FE776-64D9-43EB-9098-A3B8C923E831

Q35874750-6F2ACF7D-99B1-45A4-BE4E-B4D705D687CF

P577

Q35874750-A47DC956-9B85-46A0-A709-18F588170AFC

P5875

Q35874750-3EF90B14-7CBB-4BAA-9B86-F420A388A600

P698

Q35874750-66AC7FDD-F193-4478-B985-7EBED34C1FF8

P921

Q35874750-F65BAA41-85A4-4ABB-B18F-44EF0CE47F9F

P932

Q35874750-11F3B4CA-E285-4DA3-B437-9613C9FA5895

P356

P1433

Journal of Proteome Research

P1476

N-linked glycan structures and ...... era of ovarian cancer patients

@en

P2093

Benjamin F Mann

http://www.w3.org/2001/XMLSchema#string

Jacqueline A Vasseur

http://www.w3.org/2001/XMLSchema#string

John A Goetz

http://www.w3.org/2001/XMLSchema#string

Martin Svoboda

http://www.w3.org/2001/XMLSchema#string

Milos V Novotny

http://www.w3.org/2001/XMLSchema#string

Nancy Menning

http://www.w3.org/2001/XMLSchema#string

William R Alley

http://www.w3.org/2001/XMLSchema#string

P2860

Printed covalent glycan array for ligand profiling of diverse glycan binding proteins

Identification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in-gel electrophoresis

The human plasma proteome: history, character, and diagnostic prospects

Measuring the accuracy of diagnostic systems

Biological roles of oligosaccharides: all of the theories are correct

Glycosylation in cellular mechanisms of health and disease

Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer.

Characterization of serum biomarkers for detection of early stage ovarian cancer.

Solid-phase permethylation of glycans for mass spectrometric analysis.

Plasma proteomic pattern as biomarkers for ovarian cancer.

P304

2282-2300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/PR201070K

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221805051

http://www.w3.org/2001/XMLSchema#string

P698

22304416

http://www.w3.org/2001/XMLSchema#string

P921

P932

3321095

http://www.w3.org/2001/XMLSchema#string